Gene Nudelman: Early Hemorrhage Control Improves Patient Outcomes
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Early hemorrhage control isn’t just about stopping bleeding – it’s about improving patient outcomes.
Every minute of uncontrolled bleeding increases the risk of hemorrhagic shock, coagulopathy, organ dysfunction, greater transfusion requirements, and mortality. That’s why time to hemostasis is one of the most important factors in trauma and surgical care.
Our latest white paper explores how WoundClot supports early hemorrhage management across the continuum of care—from the point of injury and emergency departments to operating rooms, postoperative care, vascular access, and austere environments.
Key highlights include:
- Broad-spectrum use across appropriate accessible bleeding environments
- FDA-cleared in the U.S. as a hemostatic wound dressing and used internationally as a Class III implantable and bioresorbable surgical hemostat in over 50 countries
- More than a decade of clinical and commercial use with no reported product-related adverse events in company post-market surveillance
- A unique expanding gel-matrix technology that conforms to complex wounds, adheres to tissue, and helps create an effective localized hemostatic environment
- Evidence supporting the importance of earlier hemostasis in reducing mortality and major complications
The goal isn’t simply to stop bleeding – it’s to control hemorrhage early enough to prevent avoidable deterioration.
Every minute matters. Every drop counts.”

Stay updated with Hemostasis Today.
-
Aug 25, 2026, 00:07Muhammad Ali Khan: Using EHR Data to Predict Fibrotic Progression in PV and ET
-
Aug 25, 2026, 00:06Michael R. Scoma: The Vascular Dimension of Long COVID
-
Aug 24, 2026, 23:40Vimee Bindra: Your Period May Be Trying to Tell You Something
-
Aug 24, 2026, 23:30R. P. Singh: Hemophilia and HIV Relationship
-
Aug 24, 2026, 23:12Marta Velia Antonini: Hemolysis in ECMO – More Than Just a Laboratory Finding
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada